Drugs / Sodium fluoride varnish
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03818945 | Mar → Jun 2019 | dentin sensitivity | Cairo University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05791669 Comparator | Aug 2021 → Aug 2022 | dental caries | Postgraduate Institute of Dental Sciences Rohtak | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium fluoride varnish | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03818945 ↗ |
| Route | Topical | “It is a topical application with an active ingredient of 5% sodium fluoride(22,600ppm fluoride).” NCT05791669 ↗ |